KBC Group’s HUTCHMED HCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-17,958
Closed -$630K 1282
2021
Q4
$630K Buy
17,958
+12,823
+250% +$417K ﹤0.01% 813
2021
Q3
$188K Buy
+5,135
New +$202K ﹤0.01% 1083
2020
Q1
Sell
-1,978
Closed -$50K 1358
2019
Q4
$50K Hold
1,978
﹤0.01% 1408
2019
Q3
$35K Hold
1,978
﹤0.01% 1403
2019
Q2
$44K Hold
1,978
﹤0.01% 1362
2019
Q1
$60K Buy
+1,978
New +$49.3K ﹤0.01% 1309

Other funds holding HCM

KBC Group's HCM Position: Q1 2022 in Review

KBC Group sold out of HUTCHMED (HCM) in Q1 2022, closing a stake of 17,958 shares — an estimated $630K sold.

KBC Group first reported a position in HCM in Q1 2019 and held it in 6 quarters. The position peaked at $630K in Q4 2021. 130 funds tracked by Wall St. Rank hold HCM as of Q1 2022.

  • KBC Group reported no remaining HUTCHMED position as of Q1 2022 after selling out during the quarter.
  • KBC Group sold 17,958 HUTCHMED shares in Q1 2022, an estimated $630K.
  • KBC Group first reported a position in HUTCHMED in Q1 2019 and held it in 6 quarters.
  • KBC Group's HUTCHMED position peaked at $630K in Q4 2021.
  • 130 funds tracked by Wall St. Rank held HUTCHMED as of Q1 2022.

Based on KBC Group's 13F filing for Q1 2022, filed 6 May 2022.